BIVIGAM Archives | GeoInvesting

BIVIGAM

ADMA Biologics Receives a Split FDA Decision on BIVIGAM
Gallery
ADMA Biologics Receives a Split FDA Decision on BIVIGAM

Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents

ADMA Biologics Receives a Split FDA Decision on BIVIGAM

By Bill Langbein|2018-12-20T15:03:58-05:00December 20th, 2018|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: ADMA, BIVIGAM, PDUFA|

ADMA Biologics (NASDAQ:ADMA), a company specializing in the manufacturing and development [...]

0